| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetoscopy | 32 | 2024 | 426 | 4.710 |
Why?
|
| Fetofetal Transfusion | 19 | 2024 | 186 | 4.430 |
Why?
|
| Pregnancy | 108 | 2025 | 7102 | 3.240 |
Why?
|
| Placenta Accreta | 19 | 2025 | 144 | 3.160 |
Why?
|
| Pregnancy, Twin | 21 | 2023 | 168 | 2.740 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2024 | 624 | 1.920 |
Why?
|
| Delivery, Obstetric | 7 | 2022 | 253 | 1.730 |
Why?
|
| Neural Tube Defects | 11 | 2024 | 351 | 1.720 |
Why?
|
| Pregnancy Complications | 7 | 2022 | 503 | 1.650 |
Why?
|
| Pregnancy Outcome | 17 | 2023 | 592 | 1.510 |
Why?
|
| Obstetrics | 6 | 2023 | 233 | 1.500 |
Why?
|
| Ultrasonography, Prenatal | 24 | 2024 | 901 | 1.500 |
Why?
|
| Gestational Age | 25 | 2024 | 1118 | 1.450 |
Why?
|
| Cesarean Section | 20 | 2023 | 380 | 1.340 |
Why?
|
| Fetal Growth Retardation | 6 | 2023 | 216 | 1.340 |
Why?
|
| Premature Birth | 11 | 2023 | 380 | 1.320 |
Why?
|
| Placenta | 14 | 2025 | 490 | 1.290 |
Why?
|
| Female | 112 | 2025 | 64961 | 1.280 |
Why?
|
| Pre-Eclampsia | 4 | 2023 | 220 | 1.260 |
Why?
|
| Placenta Previa | 8 | 2023 | 63 | 1.180 |
Why?
|
| Prenatal Care | 9 | 2023 | 340 | 1.130 |
Why?
|
| Peripartum Period | 2 | 2024 | 31 | 1.120 |
Why?
|
| Prenatal Diagnosis | 8 | 2024 | 581 | 1.100 |
Why?
|
| Hysterectomy | 13 | 2023 | 182 | 1.090 |
Why?
|
| Fetal Membranes, Premature Rupture | 4 | 2021 | 60 | 1.090 |
Why?
|
| Critical Care | 5 | 2023 | 647 | 1.070 |
Why?
|
| Laser Therapy | 6 | 2022 | 246 | 1.040 |
Why?
|
| Retrospective Studies | 59 | 2024 | 15879 | 1.020 |
Why?
|
| Fetal Diseases | 8 | 2024 | 443 | 1.010 |
Why?
|
| Gastroschisis | 3 | 2021 | 53 | 0.970 |
Why?
|
| Infant, Newborn | 35 | 2024 | 8113 | 0.940 |
Why?
|
| Postoperative Complications | 7 | 2021 | 2998 | 0.920 |
Why?
|
| Maternal-Fetal Exchange | 2 | 2016 | 80 | 0.920 |
Why?
|
| Humans | 114 | 2025 | 122423 | 0.900 |
Why?
|
| Meningomyelocele | 7 | 2023 | 222 | 0.880 |
Why?
|
| Labor, Obstetric | 2 | 2022 | 95 | 0.820 |
Why?
|
| Blood Coagulation Disorders | 2 | 2021 | 101 | 0.820 |
Why?
|
| Weight Gain | 2 | 2016 | 377 | 0.820 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2023 | 71 | 0.810 |
Why?
|
| Gynecology | 1 | 2024 | 126 | 0.810 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 29 | 0.790 |
Why?
|
| Magnesium Sulfate | 2 | 2021 | 51 | 0.770 |
Why?
|
| Maternal Mortality | 2 | 2020 | 82 | 0.760 |
Why?
|
| Hysterotomy | 8 | 2024 | 118 | 0.760 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.750 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2021 | 29 | 0.740 |
Why?
|
| Laser Coagulation | 7 | 2023 | 128 | 0.740 |
Why?
|
| Cicatrix | 1 | 2022 | 125 | 0.730 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2024 | 103 | 0.730 |
Why?
|
| Trachea | 2 | 2019 | 201 | 0.720 |
Why?
|
| Spinal Dysraphism | 5 | 2023 | 262 | 0.710 |
Why?
|
| Adult | 55 | 2025 | 28746 | 0.710 |
Why?
|
| Blood Coagulation | 1 | 2021 | 119 | 0.700 |
Why?
|
| Laryngoscopy | 2 | 2019 | 149 | 0.660 |
Why?
|
| Airway Obstruction | 2 | 2019 | 165 | 0.660 |
Why?
|
| Lasers | 4 | 2023 | 115 | 0.650 |
Why?
|
| Intensive Care Units | 2 | 2022 | 475 | 0.620 |
Why?
|
| Maternal Death | 1 | 2018 | 8 | 0.610 |
Why?
|
| Fetus | 9 | 2023 | 579 | 0.600 |
Why?
|
| Hemangioma | 1 | 2019 | 97 | 0.590 |
Why?
|
| Bradycardia | 1 | 2018 | 60 | 0.590 |
Why?
|
| Hypothermia | 1 | 2018 | 51 | 0.590 |
Why?
|
| Placenta Diseases | 3 | 2018 | 58 | 0.560 |
Why?
|
| Fetal Weight | 4 | 2023 | 52 | 0.550 |
Why?
|
| Obstetric Labor Complications | 2 | 2018 | 96 | 0.550 |
Why?
|
| Embolism, Amniotic Fluid | 1 | 2016 | 31 | 0.540 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 218 | 0.530 |
Why?
|
| Postpartum Hemorrhage | 4 | 2023 | 90 | 0.520 |
Why?
|
| Umbilical Arteries | 4 | 2021 | 90 | 0.500 |
Why?
|
| Cohort Studies | 18 | 2023 | 4649 | 0.500 |
Why?
|
| Heart Valve Diseases | 1 | 2016 | 167 | 0.490 |
Why?
|
| Erythrocyte Transfusion | 4 | 2020 | 122 | 0.470 |
Why?
|
| Delphi Technique | 3 | 2024 | 200 | 0.470 |
Why?
|
| Amnion | 2 | 2020 | 38 | 0.440 |
Why?
|
| Young Adult | 16 | 2024 | 8805 | 0.430 |
Why?
|
| Pregnancy Trimester, Second | 7 | 2024 | 158 | 0.420 |
Why?
|
| Light Coagulation | 2 | 2023 | 24 | 0.420 |
Why?
|
| Treatment Outcome | 18 | 2024 | 12036 | 0.420 |
Why?
|
| Blood Loss, Surgical | 5 | 2019 | 141 | 0.420 |
Why?
|
| Walking | 3 | 2024 | 196 | 0.420 |
Why?
|
| Heart Defects, Congenital | 4 | 2017 | 1802 | 0.410 |
Why?
|
| Triplets | 1 | 2012 | 11 | 0.400 |
Why?
|
| Labor Presentation | 2 | 2022 | 12 | 0.400 |
Why?
|
| Urethral Obstruction | 3 | 2024 | 56 | 0.400 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2025 | 3456 | 0.380 |
Why?
|
| Amniotic Band Syndrome | 3 | 2020 | 24 | 0.380 |
Why?
|
| Diseases in Twins | 2 | 2021 | 94 | 0.370 |
Why?
|
| Consensus | 2 | 2024 | 607 | 0.370 |
Why?
|
| Hydrocephalus | 3 | 2024 | 236 | 0.370 |
Why?
|
| Iatrogenic Disease | 2 | 2022 | 130 | 0.370 |
Why?
|
| Urologic Diseases | 2 | 2021 | 44 | 0.350 |
Why?
|
| Ultrasonography, Doppler | 4 | 2020 | 197 | 0.350 |
Why?
|
| Pregnancy Trimester, First | 3 | 2022 | 111 | 0.340 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 3 | 2021 | 383 | 0.340 |
Why?
|
| Motor Activity | 3 | 2021 | 495 | 0.330 |
Why?
|
| Uterine Hemorrhage | 2 | 2020 | 47 | 0.330 |
Why?
|
| Fetal Death | 3 | 2021 | 115 | 0.320 |
Why?
|
| Patient Positioning | 2 | 2020 | 54 | 0.320 |
Why?
|
| Maternal Age | 4 | 2017 | 135 | 0.310 |
Why?
|
| Twins, Monozygotic | 4 | 2023 | 109 | 0.300 |
Why?
|
| Vasa Previa | 2 | 2019 | 8 | 0.300 |
Why?
|
| Patient Care Team | 4 | 2019 | 539 | 0.280 |
Why?
|
| Twins | 3 | 2021 | 68 | 0.270 |
Why?
|
| Intraoperative Complications | 2 | 2021 | 174 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2021 | 1677 | 0.250 |
Why?
|
| Blood Component Transfusion | 3 | 2021 | 53 | 0.250 |
Why?
|
| Nasal Lavage | 1 | 2024 | 2 | 0.250 |
Why?
|
| ROC Curve | 3 | 2022 | 552 | 0.240 |
Why?
|
| Hypoxia | 2 | 2020 | 246 | 0.240 |
Why?
|
| Ferrosoferric Oxide | 1 | 2025 | 26 | 0.240 |
Why?
|
| Prospective Studies | 4 | 2022 | 5974 | 0.230 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2014 | 17 | 0.230 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2023 | 441 | 0.220 |
Why?
|
| Pregnant Women | 2 | 2022 | 148 | 0.220 |
Why?
|
| Conservative Treatment | 1 | 2023 | 32 | 0.220 |
Why?
|
| Incidence | 5 | 2022 | 3008 | 0.220 |
Why?
|
| Polyhydramnios | 3 | 2019 | 51 | 0.220 |
Why?
|
| Risk Factors | 14 | 2023 | 9871 | 0.220 |
Why?
|
| Odds Ratio | 3 | 2021 | 1231 | 0.220 |
Why?
|
| Pulsatile Flow | 2 | 2021 | 133 | 0.220 |
Why?
|
| Survival Analysis | 3 | 2022 | 1472 | 0.210 |
Why?
|
| Angioedemas, Hereditary | 1 | 2022 | 8 | 0.210 |
Why?
|
| Angioedema | 1 | 2022 | 22 | 0.210 |
Why?
|
| Ureter | 1 | 2023 | 96 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2022 | 98 | 0.200 |
Why?
|
| Tocolytic Agents | 1 | 2021 | 12 | 0.200 |
Why?
|
| Ultrasonography | 3 | 2022 | 945 | 0.200 |
Why?
|
| Indomethacin | 1 | 2021 | 84 | 0.190 |
Why?
|
| Fertilization in Vitro | 2 | 2020 | 188 | 0.190 |
Why?
|
| Labor Stage, Second | 1 | 2021 | 20 | 0.190 |
Why?
|
| United States | 10 | 2022 | 10478 | 0.190 |
Why?
|
| Abdominal Wall | 1 | 2021 | 32 | 0.190 |
Why?
|
| Treatment Failure | 1 | 2022 | 335 | 0.190 |
Why?
|
| Practice Guidelines as Topic | 3 | 2018 | 1247 | 0.180 |
Why?
|
| Ascites | 1 | 2021 | 88 | 0.180 |
Why?
|
| Pregnancy Trimesters | 1 | 2021 | 33 | 0.180 |
Why?
|
| Neurosurgical Procedures | 2 | 2020 | 296 | 0.180 |
Why?
|
| Blood Coagulation Tests | 1 | 2021 | 60 | 0.180 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 23 | 0.180 |
Why?
|
| Respiratory Insufficiency | 1 | 2023 | 234 | 0.180 |
Why?
|
| Maternal Health Services | 1 | 2020 | 38 | 0.180 |
Why?
|
| Thrombelastography | 1 | 2021 | 55 | 0.180 |
Why?
|
| Prone Position | 1 | 2020 | 32 | 0.180 |
Why?
|
| Spina Bifida Cystica | 1 | 2020 | 35 | 0.180 |
Why?
|
| White Matter | 1 | 2022 | 181 | 0.180 |
Why?
|
| Reproductive Techniques, Assisted | 2 | 2017 | 78 | 0.170 |
Why?
|
| Pandemics | 3 | 2022 | 1103 | 0.170 |
Why?
|
| Fetal Development | 2 | 2019 | 110 | 0.170 |
Why?
|
| Birth Weight | 5 | 2022 | 334 | 0.170 |
Why?
|
| Respiration, Artificial | 1 | 2022 | 453 | 0.170 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 68 | 0.160 |
Why?
|
| Placenta Growth Factor | 1 | 2019 | 11 | 0.160 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.160 |
Why?
|
| Hypocalcemia | 1 | 2019 | 35 | 0.160 |
Why?
|
| Carbon Dioxide | 4 | 2023 | 274 | 0.160 |
Why?
|
| Catheters, Indwelling | 2 | 2021 | 156 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 42 | 0.160 |
Why?
|
| Uterine Artery | 1 | 2019 | 29 | 0.160 |
Why?
|
| Disease Management | 3 | 2018 | 513 | 0.160 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2018 | 13 | 0.160 |
Why?
|
| Polycythemia | 2 | 2016 | 42 | 0.160 |
Why?
|
| Obstetric Labor, Premature | 1 | 2019 | 85 | 0.160 |
Why?
|
| Severity of Illness Index | 4 | 2020 | 2814 | 0.160 |
Why?
|
| Case-Control Studies | 6 | 2023 | 3231 | 0.150 |
Why?
|
| Meningocele | 1 | 2018 | 20 | 0.150 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 138 | 0.150 |
Why?
|
| Angiotensin II | 1 | 2019 | 161 | 0.150 |
Why?
|
| Placental Circulation | 2 | 2020 | 23 | 0.150 |
Why?
|
| Cold Temperature | 1 | 2018 | 81 | 0.150 |
Why?
|
| Laparoscopy | 3 | 2013 | 503 | 0.150 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2017 | 3 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 121 | 0.150 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 122 | 0.150 |
Why?
|
| Hospital Rapid Response Team | 1 | 2018 | 35 | 0.150 |
Why?
|
| Heart Rate, Fetal | 1 | 2018 | 64 | 0.150 |
Why?
|
| Intestines | 1 | 2021 | 580 | 0.150 |
Why?
|
| Patient Transfer | 1 | 2018 | 101 | 0.140 |
Why?
|
| Ultrasonography, Interventional | 1 | 2019 | 196 | 0.140 |
Why?
|
| Hydrops Fetalis | 1 | 2017 | 75 | 0.140 |
Why?
|
| Cross-Sectional Studies | 3 | 2021 | 3306 | 0.140 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2017 | 50 | 0.140 |
Why?
|
| Hospital Mortality | 1 | 2022 | 996 | 0.140 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2016 | 28 | 0.140 |
Why?
|
| Cystoscopy | 1 | 2016 | 44 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 462 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2016 | 58 | 0.140 |
Why?
|
| Maternal Exposure | 1 | 2018 | 148 | 0.140 |
Why?
|
| Infertility, Female | 1 | 2017 | 165 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2016 | 65 | 0.130 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 2 | 2014 | 79 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2019 | 329 | 0.130 |
Why?
|
| Arm Injuries | 1 | 2015 | 13 | 0.130 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 135 | 0.130 |
Why?
|
| Gravidity | 1 | 2015 | 10 | 0.130 |
Why?
|
| Inositol Phosphates | 1 | 2015 | 12 | 0.130 |
Why?
|
| Inositol | 1 | 2015 | 13 | 0.130 |
Why?
|
| Simulation Training | 1 | 2018 | 139 | 0.130 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2019 | 251 | 0.130 |
Why?
|
| Ovary | 1 | 2018 | 390 | 0.130 |
Why?
|
| Lymphatic Abnormalities | 1 | 2015 | 35 | 0.120 |
Why?
|
| Pleural Effusion | 1 | 2015 | 99 | 0.120 |
Why?
|
| Mothers | 1 | 2018 | 346 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 361 | 0.120 |
Why?
|
| Hypertension, Pulmonary | 1 | 2019 | 428 | 0.120 |
Why?
|
| Prognosis | 6 | 2024 | 4492 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 378 | 0.120 |
Why?
|
| Polysaccharides | 1 | 2015 | 142 | 0.120 |
Why?
|
| Logistic Models | 4 | 2021 | 1768 | 0.110 |
Why?
|
| Term Birth | 1 | 2013 | 32 | 0.110 |
Why?
|
| Diabetes, Gestational | 1 | 2015 | 103 | 0.110 |
Why?
|
| Patient Safety | 1 | 2018 | 390 | 0.110 |
Why?
|
| Infant | 8 | 2021 | 12347 | 0.110 |
Why?
|
| Vocal Cords | 1 | 2013 | 63 | 0.110 |
Why?
|
| Fetal Therapies | 1 | 2013 | 72 | 0.110 |
Why?
|
| Receptors, Opioid, mu | 1 | 2013 | 29 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 88 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2017 | 2012 | 0.100 |
Why?
|
| Anemia | 1 | 2016 | 339 | 0.100 |
Why?
|
| Hydronephrosis | 1 | 2012 | 35 | 0.100 |
Why?
|
| Ehrlichiosis | 1 | 2011 | 10 | 0.100 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2011 | 24 | 0.100 |
Why?
|
| Angiogenic Proteins | 1 | 2011 | 16 | 0.100 |
Why?
|
| Complement System Proteins | 1 | 2011 | 58 | 0.100 |
Why?
|
| Blood Coagulation Factors | 1 | 2011 | 35 | 0.100 |
Why?
|
| Peritoneal Lavage | 1 | 2011 | 2 | 0.100 |
Why?
|
| Ovarian Cysts | 1 | 2011 | 24 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 174 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 239 | 0.090 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 105 | 0.090 |
Why?
|
| Peritonitis | 1 | 2011 | 76 | 0.090 |
Why?
|
| Dermoid Cyst | 1 | 2011 | 35 | 0.090 |
Why?
|
| Down Syndrome | 1 | 2013 | 194 | 0.090 |
Why?
|
| Body Mass Index | 1 | 2016 | 1412 | 0.090 |
Why?
|
| Laparotomy | 2 | 2023 | 136 | 0.090 |
Why?
|
| Peritoneal Neoplasms | 1 | 2010 | 27 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2013 | 439 | 0.090 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 391 | 0.090 |
Why?
|
| Predictive Value of Tests | 3 | 2021 | 2078 | 0.080 |
Why?
|
| Amniotic Fluid | 2 | 2021 | 147 | 0.080 |
Why?
|
| Mesothelioma | 1 | 2010 | 80 | 0.080 |
Why?
|
| Blood Transfusion | 2 | 2023 | 303 | 0.080 |
Why?
|
| Postnatal Care | 2 | 2019 | 51 | 0.080 |
Why?
|
| Endometrium | 1 | 2011 | 274 | 0.080 |
Why?
|
| Kidney | 2 | 2013 | 1345 | 0.080 |
Why?
|
| Perinatal Mortality | 2 | 2019 | 42 | 0.080 |
Why?
|
| Postpartum Period | 2 | 2023 | 206 | 0.080 |
Why?
|
| Male | 10 | 2024 | 59600 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 780 | 0.070 |
Why?
|
| Endometriosis | 1 | 2010 | 185 | 0.070 |
Why?
|
| Endoscopy | 2 | 2019 | 283 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 2948 | 0.070 |
Why?
|
| Thrombosis | 1 | 2011 | 517 | 0.070 |
Why?
|
| Child, Preschool | 4 | 2024 | 13840 | 0.070 |
Why?
|
| Middle Aged | 7 | 2024 | 25591 | 0.070 |
Why?
|
| Biomarkers | 2 | 2015 | 2942 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2021 | 2794 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1398 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2021 | 1874 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 81 | 0.060 |
Why?
|
| Perinatal Care | 1 | 2024 | 68 | 0.060 |
Why?
|
| Organ Sparing Treatments | 1 | 2023 | 34 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2024 | 242 | 0.050 |
Why?
|
| Connecticut | 2 | 2013 | 20 | 0.050 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2022 | 8 | 0.050 |
Why?
|
| Texas | 2 | 2021 | 3513 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 231 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 70 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2023 | 261 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 4312 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2021 | 83 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2024 | 246 | 0.050 |
Why?
|
| Perineum | 1 | 2021 | 49 | 0.050 |
Why?
|
| Contrast Media | 1 | 2025 | 464 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2024 | 1561 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 239 | 0.050 |
Why?
|
| Cerebrospinal Fluid Leak | 1 | 2020 | 43 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 83 | 0.040 |
Why?
|
| Positive-Pressure Respiration | 1 | 2020 | 83 | 0.040 |
Why?
|
| Live Birth | 1 | 2020 | 54 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2022 | 172 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 408 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2017 | 799 | 0.040 |
Why?
|
| Insufflation | 1 | 2020 | 20 | 0.040 |
Why?
|
| Lung Volume Measurements | 1 | 2019 | 67 | 0.040 |
Why?
|
| Recurrence | 1 | 2023 | 1412 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2020 | 330 | 0.040 |
Why?
|
| Oligohydramnios | 1 | 2019 | 42 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2019 | 23 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 2019 | 53 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 73 | 0.040 |
Why?
|
| Ventriculostomy | 1 | 2019 | 35 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Umbilical Veins | 1 | 2019 | 74 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 490 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 48 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 96 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 99 | 0.040 |
Why?
|
| Portal Vein | 1 | 2019 | 92 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 297 | 0.040 |
Why?
|
| Adolescent | 3 | 2024 | 18984 | 0.040 |
Why?
|
| Regression Analysis | 1 | 2020 | 750 | 0.040 |
Why?
|
| Patient Selection | 1 | 2021 | 681 | 0.040 |
Why?
|
| Placenta, Retained | 1 | 2017 | 11 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2018 | 79 | 0.040 |
Why?
|
| Meningitis | 1 | 2018 | 99 | 0.040 |
Why?
|
| Norwood Procedures | 1 | 2019 | 100 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2021 | 1280 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 77 | 0.040 |
Why?
|
| United Kingdom | 1 | 2017 | 191 | 0.040 |
Why?
|
| Isotonic Solutions | 1 | 2017 | 35 | 0.040 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 163 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2019 | 3306 | 0.030 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2017 | 109 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 289 | 0.030 |
Why?
|
| Menorrhagia | 1 | 2017 | 74 | 0.030 |
Why?
|
| Breech Presentation | 1 | 2016 | 21 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2017 | 164 | 0.030 |
Why?
|
| Heart Atria | 1 | 2019 | 308 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 282 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 1403 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 175 | 0.030 |
Why?
|
| Prevalence | 2 | 2013 | 2371 | 0.030 |
Why?
|
| Critical Illness | 1 | 2021 | 588 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 126 | 0.030 |
Why?
|
| Biometry | 1 | 2017 | 129 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 77 | 0.030 |
Why?
|
| Arm | 1 | 2015 | 75 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 266 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1378 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2017 | 376 | 0.030 |
Why?
|
| Random Allocation | 1 | 2015 | 415 | 0.030 |
Why?
|
| Crown-Rump Length | 1 | 2014 | 5 | 0.030 |
Why?
|
| Echocardiography | 1 | 2019 | 1067 | 0.030 |
Why?
|
| Drainage | 1 | 2015 | 254 | 0.030 |
Why?
|
| Leukomalacia, Periventricular | 1 | 2013 | 13 | 0.030 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 391 | 0.030 |
Why?
|
| Abortion, Eugenic | 1 | 2013 | 9 | 0.030 |
Why?
|
| Karyotype | 1 | 2013 | 29 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2019 | 1300 | 0.030 |
Why?
|
| Algorithms | 1 | 2020 | 1577 | 0.030 |
Why?
|
| Umbilical Cord | 1 | 2013 | 55 | 0.030 |
Why?
|
| Nitrates | 1 | 2013 | 27 | 0.030 |
Why?
|
| Retinopathy of Prematurity | 1 | 2013 | 56 | 0.030 |
Why?
|
| Nitrites | 1 | 2013 | 45 | 0.030 |
Why?
|
| Abortion, Induced | 1 | 2013 | 77 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 1082 | 0.030 |
Why?
|
| Placentation | 1 | 2013 | 54 | 0.030 |
Why?
|
| Lung | 1 | 2020 | 1487 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2013 | 237 | 0.030 |
Why?
|
| Stents | 1 | 2019 | 864 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 2013 | 186 | 0.030 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 141 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1005 | 0.030 |
Why?
|
| Narcotic Antagonists | 1 | 2013 | 103 | 0.030 |
Why?
|
| Liver | 1 | 2019 | 1858 | 0.030 |
Why?
|
| Secondary Prevention | 1 | 2013 | 208 | 0.020 |
Why?
|
| Tick-Borne Diseases | 1 | 2011 | 10 | 0.020 |
Why?
|
| Reference Values | 1 | 2013 | 695 | 0.020 |
Why?
|
| Omentum | 1 | 2011 | 47 | 0.020 |
Why?
|
| Dissection | 1 | 2011 | 53 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 411 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 714 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2011 | 180 | 0.020 |
Why?
|
| Syndrome | 1 | 2013 | 1122 | 0.020 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2013 | 184 | 0.020 |
Why?
|
| Pelvic Pain | 1 | 2010 | 27 | 0.020 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2013 | 237 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 2013 | 233 | 0.020 |
Why?
|
| Survival Rate | 1 | 2015 | 2001 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 872 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 581 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 1214 | 0.020 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2011 | 237 | 0.020 |
Why?
|
| Sepsis | 1 | 2013 | 478 | 0.020 |
Why?
|
| Animals | 2 | 2025 | 33897 | 0.020 |
Why?
|
| Mice | 1 | 2025 | 17636 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 18781 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3661 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 4987 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3073 | 0.010 |
Why?
|
| Child | 1 | 2022 | 24118 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 2391 | 0.010 |
Why?
|